Zhong W, Uss A S, Ferrari E, Lau J Y, Hong Z
Department of Antiviral Therapy, Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539, USA.
J Virol. 2000 Feb;74(4):2017-22. doi: 10.1128/jvi.74.4.2017-2022.2000.
RNA-dependent RNA polymerase (RdRp) encoded by positive-strand RNA viruses is critical to the replication of viral RNA genome. Like other positive-strand RNA viruses, replication of hepatitis C virus (HCV) RNA is mediated through a negative-strand intermediate, which is generated through copying the positive-strand genomic RNA. Although it has been demonstrated that HCV NS5B alone can direct RNA replication through a copy-back primer at the 3' end, de novo initiation of RNA synthesis is likely to be the mode of RNA replication in infected cells. In this study, we demonstrate that a recombinant HCV NS5B protein has the ability to initiate de novo RNA synthesis in vitro. The NS5B used HCV 3' X-tail RNA (98 nucleotides) as the template to synthesize an RNA product of monomer size, which can be labeled by ¿gamma-(32)Pnucleoside triphosphate. The de novo initiation activity was further confirmed by using small synthetic RNAs ending with dideoxynucleotides at the 3' termini. In addition, HCV NS5B preferred GTP as the initiation nucleotide. The optimal conditions for the de novo initiation activity have been determined. Identification and characterization of the de novo priming or initiation activity by HCV NS5B provides an opportunity to screen for inhibitors that specifically target the initiation step.
正链RNA病毒编码的RNA依赖性RNA聚合酶(RdRp)对病毒RNA基因组的复制至关重要。与其他正链RNA病毒一样,丙型肝炎病毒(HCV)RNA的复制通过负链中间体介导,该中间体通过复制正链基因组RNA产生。尽管已证明单独的HCV NS5B可以通过3'端的回环引物指导RNA复制,但RNA合成的从头起始可能是感染细胞中RNA复制的模式。在本研究中,我们证明重组HCV NS5B蛋白具有在体外从头起始RNA合成的能力。该NS5B以HCV 3' X尾RNA(98个核苷酸)为模板合成单体大小的RNA产物,该产物可用γ-(32)P核苷三磷酸标记。通过使用在3'末端以双脱氧核苷酸结尾的小合成RNA进一步证实了从头起始活性。此外,HCV NS5B优先选择GTP作为起始核苷酸。已经确定了从头起始活性的最佳条件。HCV NS5B从头引发或起始活性的鉴定和表征为筛选特异性靶向起始步骤的抑制剂提供了机会。